For citations:
Kolbin A.S., Belousov D.Yu. Chinese experience on using RWE to support drug research, development and evaluation. Real-World Data & Evidence. 2022;2(1):17-27. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-8. EDN: UJOEUB
Fullscreen
Popular articles
Vol 3, No 1 (2023)
Vol 3, No 2 (2023)
Vol 3, No 4 (2023)
Vol 4, No 1 (2024)
Vol 4, No 2 (2024)
Vol 4, No 3 (2024)
Article Tools
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)
About the Authors
Keywords
COVID-19
EAEU
FDA
NICE
RWD
RWE
adverse drug reactions
big data
clinical pharmacology
clinical registries
health technology assessment
observational study
oncology
pharmacovigilance
real-world clinical practice
real-world data
real-world evidence
recommendations
regulatory approaches
resolution
vaccination
